[Skip to Content]
[Skip to Content Landing]
Controversies in Neurology
May 2003

Resolved: NASCET and ACAS Need Not Be RepeatedThe Affirmative Position

Author Affiliations

From the Division of Vascular Surgery, Geffen School of Medicine, University of California Los–Angeles.

 

STEVEN T.DEKOSKYMD

Arch Neurol. 2003;60(5):775-778. doi:10.1001/archneur.60.5.775

THE NASCET1 and the ACAS2 were the largest and best-organized trials affecting the management of extracranial carotid arteriosclerosis. Both trials have clearly defined patient populations that benefit from carotid endarterectomy compared with best medical management.

First Page Preview View Large
First page PDF preview
First page PDF preview
×